Carter, K. C., Sundar, S., Spickett, C., Pereira, O. C., & Mullen, A. B. (2003). The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis. American Society for Microbiology.

Carter, K. C., S. Sundar, C. Spickett, O. C. Pereira, and A. B. Mullen. The In Vivo Susceptibility of Leishmania Donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed By Inhibiting Glutathione Biosynthesis. American Society for Microbiology, 2003.

Carter, K. C., et al. The In Vivo Susceptibility of Leishmania Donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed By Inhibiting Glutathione Biosynthesis. American Society for Microbiology, 2003.